{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:32:28Z","timestamp":1781076748741,"version":"3.54.1"},"reference-count":44,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:sec><jats:title>Object<\/jats:title><jats:p>Vestibular schwannomas (VS) are common benign tumors of the vestibular nerve that cause significant morbidity. The current treatment strategies for VS include surgery or radiation, with each treatment option having associated complications and side effects. The transcriptional landscape of schwannoma remains largely unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study the authors performed gene-expression profiling of 49 schwannomas and 7 normal control vestibular nerves to identify tumor-specific gene-expression patterns. They also interrogated whether schwannomas comprise several molecular subtypes using several transcription-based clustering strategies. The authors also performed in vitro experiments testing therapeutic inhibitors of over-activated pathways in a schwannoma cell line, namely the PI3K\/AKT\/mTOR pathway.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The authors identified over 4000 differentially expressed genes between controls and schwannomas with network analysis, uncovering proliferation and anti-apoptotic pathways previously not implicated in VS. Furthermore, using several distinct clustering technologies, they could not reproducibly identify distinct VS subtypes or significant differences between sporadic and germline NF2\u2013associated schwannomas, suggesting that they are highly similar entities. The authors identified overexpression of PI3K\/AKT\/mTOR signaling networks in their geneexpression study and evaluated this pathway for therapeutic targeting. Testing the compounds BEZ235 and PKI-587, both novel dual inhibitors of PI3K and mTOR, attenuated tumor growth in a preclinical cell line model of schwannoma (HEI-293). In vitro findings demonstrated that pharmacological inhibition of the PI3K\/AKT\/mTOR pathway with next-generation compounds led to decreased cell viability and increased cell death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These findings implicate aberrant activation of the PI3K\/AKT\/mTOR pathway as a molecular mechanism of pathogenesis in VS and suggest inhibition of this pathway as a potential treatment strategy.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2014.6.jns131433","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T08:00:47Z","timestamp":1411459247000},"page":"1434-1445","source":"Crossref","is-referenced-by-count":36,"title":["Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma"],"prefix":"10.3171","volume":"121","author":[{"given":"Sameer","family":"Agnihotri","sequence":"first","affiliation":[{"name":"Arthur & Sonia Labatt Brain Tumour Research Centre and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Gugel","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Remke","sequence":"additional","affiliation":[{"name":"Arthur & Sonia Labatt Brain Tumour Research Centre and"},{"name":"Program in Developmental & Stem Cell Biology, The Hospital for Sick Children, Toronto;"},{"name":"Department of Laboratory Medicine & Pathobiology, University of Toronto;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Bornemann","sequence":"additional","affiliation":[{"name":"Neuropathology, University of T\u00fcbingen;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Pantazis","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, University of Marburg; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Mack","sequence":"additional","affiliation":[{"name":"Arthur & Sonia Labatt Brain Tumour Research Centre and"},{"name":"Program in Developmental & Stem Cell Biology, The Hospital for Sick Children, Toronto;"},{"name":"Department of Laboratory Medicine & Pathobiology, University of Toronto;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shih","sequence":"additional","affiliation":[{"name":"Arthur & Sonia Labatt Brain Tumour Research Centre and"},{"name":"Program in Developmental & Stem Cell Biology, The Hospital for Sick Children, Toronto;"},{"name":"Department of Laboratory Medicine & Pathobiology, University of Toronto;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Singh","sequence":"additional","affiliation":[{"name":"Arthur & Sonia Labatt Brain Tumour Research Centre and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin","family":"Sabha","sequence":"additional","affiliation":[{"name":"Arthur & Sonia Labatt Brain Tumour Research Centre and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Arthur & Sonia Labatt Brain Tumour Research Centre and"},{"name":"Program in Developmental & Stem Cell Biology, The Hospital for Sick Children, Toronto;"},{"name":"Department of Laboratory Medicine & Pathobiology, University of Toronto;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Tatagiba","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelareh","family":"Zadeh","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Toronto Western Hospital, University of Toronto, Ontario, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Krischek","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"},{"name":"Department of Neurosurgery, University of Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns131433","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.1158\/0008-5472.CAN-07-5849","article-title":"Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma","volume":"68","author":"Ammoun","year":"2008"},{"key":"b2-jns131433","series-title":"Glia","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/glia.22391","article-title":"The role of insulin-like growth factors signaling in merlin-deficient human schwannomas","volume":"60","author":"Ammoun","year":"2012"},{"key":"b3-jns131433","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/onc.2011.357","article-title":"Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and survival","volume":"31","author":"Ammoun","year":"2012"},{"key":"b4-jns131433","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1215\/15228517-2007-027","article-title":"Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the literature","volume":"9","author":"Balasubramaniam","year":"2007"},{"key":"b5-jns131433","series-title":"Otol Neurotol","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/MAO.0b013e318206fc3d","article-title":"EGF and bFGF promote invasion that is modulated by PI3\/Akt kinase and Erk in vestibular schwannoma","volume":"32","author":"Blair","year":"2011"},{"key":"b6-jns131433","series-title":"Nat Rev Mol Cell Biol","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nrm882","article-title":"ERM proteins and merlin: integrators at the cell cortex","volume":"3","author":"Bretscher","year":"2002"},{"key":"b7-jns131433","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1038\/onc.2008.247","article-title":"The PTEN-PI3K pathway: of feedbacks and cross-talks","volume":"27","author":"Carracedo","year":"2008"},{"key":"b8-jns131433","series-title":"Int J Angiol","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1055\/s-0032-1302436","article-title":"Two-year follow-up of sirolimus-eluting stents versus paclitaxeleluting stents in acute myocardial infarction","volume":"21","author":"Erdim","year":"2012"},{"key":"b9-jns131433","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.expneurol.2009.04.019","article-title":"PAK kinase regulates Rac GTPase and is a potential target in human schwannomas","volume":"218","author":"Flaiz","year":"2009"},{"key":"b10-jns131433","series-title":"Glia","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/glia.20629","article-title":"Impaired intercellular adhesion and immature adherens junctions in merlin-deficient human primary schwannoma cells","volume":"56","author":"Flaiz","year":"2008"},{"key":"b11-jns131433","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1101\/gad.14.13.1617","article-title":"Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2","volume":"14","author":"Giovannini","year":"2000"},{"key":"b12-jns131433","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007"},{"key":"b13-jns131433","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.1038\/onc.2010.363","article-title":"Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas","volume":"29","author":"Hadfield","year":"2010"},{"key":"b14-jns131433","series-title":"Histopathology","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1365-2559.2009.03440.x","article-title":"Activation of ERK, AKT and JNK signalling pathways in human schwannomas in situ","volume":"55","author":"Hilton","year":"2009"},{"key":"b15-jns131433","series-title":"Mol Cell Biol","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1128\/MCB.01581-08","article-title":"NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth","volume":"29","author":"James","year":"2009"},{"key":"b16-jns131433","series-title":"Mol Cancer Res","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1158\/1541-7786.MCR-11-0425-T","article-title":"Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types","volume":"10","author":"James","year":"2012"},{"key":"b17-jns131433","series-title":"BMC Genomics","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2164-6-35","article-title":"Silhouette scores for assessment of SNP genotype clusters","volume":"6","author":"Lovmar","year":"2005"},{"key":"b18-jns131433","series-title":"PLoS ONE","doi-asserted-by":"publisher","first-page":"e56199","DOI":"10.1371\/journal.pone.0056199","article-title":"Similar trends in serum VEGF-D levels and kidney angiomyolipoma responses with longer duration sirolimus treatment in adults with tuberous sclerosis","volume":"8","author":"Malinowska","year":"2013"},{"key":"b19-jns131433","series-title":"Clin Otolaryngol","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1749-4486.2008.01715.x","article-title":"Conservative versus primary surgical treatment of acoustic neuromas: a comparison of rates of facial nerve and hearing preservation","volume":"33","author":"Martin","year":"2008"},{"key":"b20-jns131433","series-title":"Neoplasia","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/sj.neo.7900265","article-title":"Detection of spontaneous schwannomas by MRI in a transgenic murine model of neurofibromatosis type 2","volume":"4","author":"Messerli","year":"2002"},{"key":"b21-jns131433","series-title":"Semin Cell Dev Biol","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.semcdb.2003.12.022","article-title":"PDK1, the master regulator of AGC kinase signal transduction","volume":"15","author":"Mora","year":"2004"},{"key":"b22-jns131433","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1158\/0008-5472.CAN-08-4475","article-title":"Human schwannomas express activated platelet-derived growth factor receptors and ckit and are growth inhibited by Gleevec (Imatinib Mesylate)","volume":"69","author":"Mukherjee","year":"2009"},{"key":"b23-jns131433","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1200\/JCO.2009.27.4324","article-title":"Medulloblastoma comprises four distinct molecular variants","volume":"29","author":"Northcott","year":"2011"},{"key":"b24-jns131433","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","article-title":"Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma","volume":"17","author":"Noushmehr","year":"2010"},{"key":"b25-jns131433","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"O'Reilly","year":"2006"},{"key":"b26-jns131433","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1200\/JCO.2011.36.2798","article-title":"FSTL5 is a marker of poor prognosis in non-WNT\/non-SHH medulloblastoma","volume":"29","author":"Remke","year":"2011"},{"key":"b27-jns131433","series-title":"Cancer Res","first-page":"6885","article-title":"Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis","volume":"61","author":"Rickman","year":"2001"},{"key":"b28-jns131433","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"18200","DOI":"10.1073\/pnas.0405971102","article-title":"Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L","volume":"101","author":"Rong","year":"2004"},{"key":"b29-jns131433","series-title":"Nature","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2","volume":"363","author":"Rouleau","year":"1993"},{"key":"b30-jns131433","series-title":"PLoS ONE","doi-asserted-by":"publisher","first-page":"e39412","DOI":"10.1371\/journal.pone.0039412","article-title":"Investigation of the in vitro therapeutic efficacy of nilotinib in immortalized human NF2-null vestibular schwannoma cells","volume":"7","author":"Sabha","year":"2012"},{"key":"b31-jns131433","series-title":"Mol Cell","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006"},{"key":"b32-jns131433","series-title":"Science","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005"},{"key":"b33-jns131433","series-title":"Nature","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nature04869","article-title":"Ras, PI(3)K and mTOR signalling controls tumour cell growth","volume":"441","author":"Shaw","year":"2006"},{"key":"b34-jns131433","series-title":"Am J Pathol","first-page":"1649","article-title":"Universal absence of merlin, but not other ERM family members, in schwannomas","volume":"151","author":"Stemmer-Rachamimov","year":"1997"},{"key":"b35-jns131433","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","article-title":"Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma","volume":"22","author":"Sturm","year":"2012"},{"key":"b36-jns131433","series-title":"Int J Oncol","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3892\/ijo.2013.1798","article-title":"Microarray analysis of gene expression in vestibular schwannomas reveals SPP1\/ MET signaling pathway and androgen receptor deregulation","volume":"42","author":"Torres-Martin","year":"2013"},{"key":"b37-jns131433","series-title":"Cell","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","article-title":"A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor","volume":"72","author":"Trofatter","year":"1993"},{"key":"b38-jns131433","series-title":"Annu Rev Biochem","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.biochem.70.1.535","article-title":"Synthesis and function of 3-phosphorylated inositol lipids","volume":"70","author":"Vanhaesebroeck","year":"2001"},{"key":"b39-jns131433","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010"},{"key":"b40-jns131433","series-title":"Bioinformatics","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010"},{"key":"b41-jns131433","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ccr.2011.07.007","article-title":"Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma","volume":"20","author":"Witt","year":"2011"},{"key":"b42-jns131433","series-title":"Curr Opin Genet Dev","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.gde.2009.11.002","article-title":"Targeting the PI3K signaling pathway in cancer","volume":"20","author":"Wong","year":"2010"},{"key":"b43-jns131433","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1074\/jbc.C100553200","article-title":"p21-activated kinase links Rac\/Cdc42 signaling to merlin","volume":"277","author":"Xiao","year":"2002"},{"key":"b44-jns131433","series-title":"Blood","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1182\/blood-2006-06-030833","article-title":"Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML","volume":"109","author":"Zeng","year":"2007"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/121\/6\/article-p1434.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/121\/6\/article-p1434.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/121\/6\/article-p1434.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:28:15Z","timestamp":1658708895000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/121\/6\/article-p1434.xml"}},"subtitle":["Laboratory investigation"],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":44,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2014.6.jns131433","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}